NAT-ERIBULIN
NAT-ERIBULIN
Approved
DIN Number
02539136
Drug Class
Human
Market Date
Jan 8, 2024
Company
HC
natco pharma (canada) inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02539136
AIG Number0153064001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01XX41 ERIBULIN
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
ERIBULIN MESYLATEActive
Strength: 0.5 MG / ML
Monograph: ERIBULIN MESYLATE